Emergent BioSolutions Inc. signed a five-year agreement with Calgary-based biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine...
Therapeutics
Shanghai-based Everest Medicines said it signed a licence agreement with Providence Therapeutics to make and sell the Canadian biotechnology company’s...
TORONTO -- Trillium Therapeutics Inc. has signed a deal to be bought by Pfizer Inc. in an agreement valued at...
Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to...